Prospective observational study to assess the long term safety profile of venetoclax in a Swedish cohort of Chronic Lymphocytic Leukaemia (CLL) patients

12/06/2017
05/06/2026
EU PAS number:
EUPAS19010
Study
Ongoing
Documents
Study protocol
Initial protocol
English (3.1 MB - PDF) View document
Updated protocol
English (2.16 MB - PDF) View document
English (1.95 MB - PDF) View document
Study results
Study report
Other information